EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities

Yongjun Kan, Li Zhao, Chang Jiang, Wenxiong Lin, Wensheng Pang, Yingying Liu, Juan Hu

Pharmaceuticals · 17.11.2026 · 19 (11) · 1827

DOI: 10.3390/ph19111827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 17.11.2026. Verfasst von Yongjun Kan und 6 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals given the same medicinal polysaccharide can differ in substrate utilization, metabolite production and host response. Accessible glycan structure, effective colonic exposure and the recipient’s carbohydrate-active enzyme (CAZyme) systems help explain these differences. This review examines compatibility from microbial substrate acquisition to host effects and separates substrate utilization, microbial products and host outcomes. Medicinal-glycan studies identify selective utilization, substrate-induced polysaccharide utilization loci and catalytic reactions, with genetic evidence for selected systems. Utilization specificity and prevalence of compatible functions jointly influence community responses, while enzyme induction, competition, metabolic exchange, absorption, direct glycan recognition and preparation composition shape conversion and host exposure. We propose selecting candidate predictors from these response processes and testing them against prespecified endpoints. Human dietary-fiber studies provide complementary evidence for taxonomic prediction, functional biomarkers and fermentation-guided choice. The available evidence supports a proof-of-concept rationale, not a clinically validated rule for selecting medicinal polysaccharides, and the reviewed studies do not establish improved host outcomes from a matching rule. The key test is whether explicit glycan–utilization matching improves prediction beyond taxonomy and the separate effects of structure and function. Paired comparisons under common validation conditions can isolate that contribution, while baseline fermentation can add information when screening and validation endpoints are measured independently. Predicting response to one preparation and choosing the best preparation require different evidence. The practical value of matching depends on improving host outcomes over a common preparation or usual selection practice.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kan, Y., Zhao, L., Jiang, C., Lin, W., Pang, W., Liu, Y., & Hu, J. (2026). From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities. Pharmaceuticals, 19(11), 1827. https://doi.org/10.3390/ph19111827

Vancouver

Kan Y, Zhao L, Jiang C, Lin W, Pang W, Liu Y, et al. From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities. Pharmaceuticals. 2026;19(11):1827. doi:10.3390/ph19111827

BibTeX
@article{Kan2026,
  author = {Kan, Yongjun and Zhao, Li and Jiang, Chang and Lin, Wenxiong and Pang, Wensheng and Liu, Yingying and Hu, Juan},
  title = {From Glycan–CAZyme Compatibility to Personalized Medicinal Polysaccharide Interventions: Mechanistic Evidence, Response Variability, and Predictive Opportunities},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1827},
  doi = {10.3390/ph19111827}
}
Kostenlos starten →